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Nedd4 belongs to a family of ubiquitin-protein ligases
that is characterized by 2–4 WW domains, a carboxyl-
terminal Hect (homologous to E6-AP Carboxyl terminus)-
domain and in most cases an amino-terminal C2 domain.
We had previously identified a series of proteins that
associates with the WW domains of Nedd4. In this paper,
we demonstrate that one of the Nedd4-binding proteins,
N4WBP5, belongs to a small group of evolutionarily con-
served proteins with three transmembrane domains.
N4WBP5 binds Nedd4 WW domains via the two PPXY
motifs present in the amino terminus of the protein. In
addition to Nedd4, N4WBP5 can interact with the WW
domains of a number of Nedd4 family members and is
ubiquitinated. Endogenous N4WBP5 localizes to the
Golgi complex. Ectopic expression of the protein dis-
rupts the structure of the Golgi, suggesting that
N4WBP5 forms part of a family of integral Golgi mem-
brane proteins. Based on previous observations in yeast,
we propose that N4WBP5 may act as an adaptor for
Nedd4-like proteins and their putative targets to control
ubiquitin-dependent protein sorting and trafficking.
Ubiquitin-mediated protein modification regulates a variety
of cellular processes including protein turnover and trafficking,
endocytosis, transcriptional regulation, activation of transcrip-
tion factors, and virus budding (reviewed in Refs. 1 and 2). The
conjugation of ubiquitin to a protein substrate is a multistep
process (1, 2). In an initial ATP-requiring step, a thioester is
formed between the carboxyl terminus of ubiquitin and an
internal cysteine residue of a ubiquitin-activating enzyme
(E1).1 Activated ubiquitin is then transferred to a specific cys-
teine of one of several ubiquitin-conjugating enzymes (E2). E2
enzymes may donate ubiquitin directly to protein substrates,
resulting in branched protein conjugates in which the carboxyl
terminus of ubiquitin is linked by an isopeptide bond to specific
internal lysine residues of target proteins. Substrates are also
recognized by associated substrate-recognition proteins known
as E3 proteins or ubiquitin-protein ligases, which play a major
role in defining the substrate specificity of the ubiquitin system
(1, 2). Hect (homologous to E6-AP Carboxyl terminus) domain
containing proteins, which include members of the Nedd4 fam-
ily, are a major class of E3s (3, 4).
Nedd4 was originally identified as a developmentally regu-
lated gene that is highly expressed in the mouse embryonic
central nervous system (5). Further analysis revealed that the
expression of Nedd4 is not restricted to the embryonic central
nervous system, and that it is expressed at varying levels in
several embryonic and adult tissues (6). The Nedd4 protein has
three types of protein domains, an amino-terminal C2 domain
(involved in Ca2-dependent binding of membrane phospholip-
ids and proteins), three or four WW protein-protein interaction
domains, and a Hect ubiquitin-protein ligase domain at the
carboxyl terminus. WW domains consist of 35 amino acids
and are often found in proteins in multiple copies (7). They bind
to several target sequences including the PY motif (PPXY),
PPLP motif, and phosphoserine and phosphothreonine resi-
dues (8–11).
The Nedd4 family consists of a number of proteins that share
the same modular structure as Nedd4 (12). Although the func-
tion of the majority of the Nedd4 family members is not known,
these proteins have been implicated in a variety of cellular
processes including endocytosis, TGF- signaling, virus bud-
ding, transcription, and protein trafficking (reviewed in Refs.
12–14). Nedd4 homologues exist in both Saccharomyces cerevi-
siae and Schizosaccahromyces pombe. The S. cerevisiae protein,
Rsp5 is the best studied of all Nedd4 family members. Rsp5 is
an essential protein in yeast that regulates the ubiquitin-me-
diated endocytosis and/or turnover of several membrane pro-
teins (reviewed in Refs. 13 and 14). Additionally, Rsp5 is be-
lieved to play a role in minichromosome maintenance (15),
protein sorting and trafficking (16–18), transcriptional regula-
tion (19), and regulated proteasome-dependent processing of
SPT23 transcription factor (20, 21). Although mammalian
Nedd4, a widely expressed protein, has been implicated in
various cellular processes, much less is known about the spe-
cific pathways and proteins regulated by Nedd4. The best char-
acterized targets of Nedd4 and its close homologue Nedd4–2/
KIAA0439 are the epithelial Na channel (ENaC) subunits,
which interact with Nedd4 WW domains via the PY motifs
present in the cytosolic carboxyl termini of each subunit (22–
28). As the widespread expression of Nedd4 suggests that it
may have additional targets, we carried out a far-Western
protein expression screen using the WW domains of Nedd4 as
a probe and identified eight new Nedd4 WW domain-binding
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proteins from mouse embryo cDNA libraries (29). Of these, one
encoding a novel protein, which we named N4WBP5, was rep-
resented in 25% of clones obtained from the screen (29). In this
paper, we have further characterized N4WBP5 and report that
it is a novel evolutionarily conserved protein with a potential
role in Golgi structure and function.
EXPERIMENTAL PROCEDURES
Sequence Retrieval and Homology Analysis—Hydrophobicity of the
N4WBP5 protein was estimated using the Kyte-Doolittle program, and
transmembrane domains were predicted using the TMPRED program.
Multiple sequence alignments and construction of phylogenetic trees
were carried out using bionavigator software packages Protpars and
Protml at the Australian National Genome Information Services server.
Northern Blot Analysis—A full-length mouse N4WBP5 cDNA was
used as a probe for RNA blot analysis using a multiple tissue Northern
blot containing poly(A) RNA from mouse tissues (CLONTECH). A
-actin cDNA probe (CLONTECH) was used as a loading control probe.
A full-length human N4WBP5 cDNA probe was used to probe a human
multiple tissue expression array (CLONTECH) containing poly(A)
RNA samples normalized against eight housekeeping mRNAs.
Bacterial Expression Plasmids and Production of GST Fusion Pro-
teins—The expression constructs used to generate the various WW
domain proteins fused to glutathione S-transferase (GST) have been
described previously (24, 27). The constructs for N4WBP5-GST fusion
proteins that were used as probes in far-Western assays and for anti-
body production were generated by PCR amplification of the N4WBP5
cDNA encoding the amino-terminal 113 residues and cloning into
BamHI/EcoRI sites of pGEX-2TK (Amersham Biosciences, Inc.).
N4WBP5 PY motif mutants in which the Tyr residue was replaced by
Ala were generated by PCR mutagenesis and verified by automated
sequencing (PerkinElmer Life Sciences). GST fusion proteins were pro-
duced and purified as described previously (24).
Antibody Production and Affinity Purification—The purified
N4WBP5-GST fusion protein was used to inoculate two rabbits (0.5 mg
of protein/rabbit). Rabbits were boosted three times at three-week in-
tervals with 0.5 mg of protein/boost/rabbit. Sera were collected and
tested on recombinant protein. The serum sample that showed the
highest reactivity with N4WBP5 was affinity-purified. Initially poly-
clonal antibodies were passed through a column of GST coupled to
cyanogen bromide-activated Sepharose 4 (Amersham Biosciences, Inc.)
to remove GST-specific antibodies. Flow through from this step was
affinity-purified against N4WBP5-GST coupled to cyanogen bromide-
activated Sepharose 4. Bound proteins were eluted into Tris-HCl, pH
8.6, with 100 mM glycine, pH 2.5, and dialysed against phosphate-
buffered saline. Affinity-purified antibodies were diluted in 50% glyc-
erol and stored at 20 °C.
SDS-PAGE and Far-Western Analysis—32P-Labeled protein probes
were produced by directly labeling the appropriate GST fusion protein
using protein kinase A (New England Biolabs). Glutathione beads
containing bound fusion protein were incubated with protein kinase
A and [-32P]ATP in a buffer containing 20 mM Tris-HCl, pH 7.5, 100
mM NaCl, 12 mM MgCl2, and 1 mM dithiothreitol for 60 min at 4 °C.
Beads were washed five times in phosphate-buffered saline, and
labeled protein was eluted with glutathione buffer. To prepare WW
domain protein filters, 1 g of each induced GST fusion protein
lysate was resolved on SDS-PAGE gels and transferred to nitrocellulose
membrane (Schleicher & Schuell). Membranes were blocked in Hyb75
(30) and then hybridized with 32P-labeled N4WBP5 protein probes with
both PY motifs intact, PY motif 2 intact or with PY motif 1 intact for 4 h
at 4 °C in Hyb75. Membranes were washed three times in Hyb75 and
exposed to x-ray film.
Mammalian Expression Plasmids—pcDNA3-N4WBP5-FLAG was
generated by PCR2 amplification of the N4WBP5 open reading frame
with a FLAG tag engineered at the carboxyl terminus and cloning into
the EcoRI site of pcDNA3 (Invitrogen). pcDNA3-N4WBP5-FLAG with
PY motifs mutated was generated by PCR mutagenesis and verified by
automated sequencing. pCXN2-Nedd4 was generated by relieving the
open reading frame of Nedd4 using HaeII and Sap I (New England
Biolabs) end filling using T4 DNA polymerase and cloning into pCXN2
(31). The pCXN2-Nedd4 cysteine mutant was produced by subjecting a
pBluescript-Nedd4 construct to Kunkel mutagenesis (32). Mutant
clones were verified by sequencing, and then the mutagenized open
reading frame of Nedd4 was subcloned into pCXN2. pcDNA3-Nedd4
WW domains (N4WBP5/Nedd4 WW) were generated by PCR amplifi-
cation of the region of Nedd4 encoding for the WW domains and cloning
into BamHI/EcoRI sites of pcDNA3. The HA-ubiquitin expression plas-
mid was kindly provided by Dr. Dirk Bohmann (Aab Institute of Bio-
medical Sciences, Rochester, NY).
Cell Lines, Transfections, Immunoprecipitations, and Western Blot-
ting—All cell lines with the exception of HEK 293T were grown in
Dulbecco’s modified Eagle’s medium, 10% fetal calf serum at 37 °C with
5% CO2. HEK 293T cells were grown in RPMI 1640 medium supple-
mented with 10% fetal calf serum. Transfections were performed using
FuGENE6 (Roche Molecular Biochemicals) according to manufacturer
instructions. Immunoprecipitations were performed by harvesting cells
in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10% glycerol, 1%
Triton X-100, 10 mM EDTA, complete protease inhibitor mixture (Roche
Molecular Biochemicals) and incubating lysates for 2 h at 4 °C with the
appropriate antibody and then for 2 h at 4 °C with protein G-Sepharose
(Amersham Biosciences, Inc.). Immunoprecipitates were washed three
times in lysis buffer and once in phosphate-buffered saline and then
subjected to SDS-PAGE.
Immunoblots were performed using the following primary antibodies
anti-FLAG M2 (Sigma) at 1/1000, Nedd4ab1 (1/4000) (6), anti-N4WBP5
(1 g/ml), and anti--actin (Sigma) at 1/2000 and secondary antibodies
anti-mouse and anti-rabbit IgG conjugated to horseradish peroxidase
(Amersham Biosciences, Inc.). For the anti-N4WBP5 immunoblot, cells
were harvested in lysis buffer (20 mM HEPES, pH 7.5, 50 mM KCl, 5 mM
EGTA, 2 mM MgCl2, 1 mM EDTA, complete protease inhibitor mixture)
and disrupted by freeze thaw. An equivalent amount of protein from
each cell type was subjected to SDS-PAGE. Detection of bound antibody
was achieved using ECL (Amersham Biosciences, Inc.).
Pulse-chase Experiments—For pulse-chase experiments, COS cells
were transfected in triplicate with 1 g of pcDNA3-N4WBP5-FLAG
alone or with 1 g of pcDNA3-N4WBP5-FLAG and 3 g of pCXN2,
pCXN2-Nedd4 (Nedd4), or pCXN2-Nedd4 cysteine mutant and incu-
bated for 24 h. Cells were incubated in methionine and cysteine-free
medium (ICN) for 20 min and labeled for 2 h in the same medium
containing 0.1 mCi/ml [35S]L-Met (ICN). Cells were washed in Dulbec-
co’s modified Eagle’s medium, 10% fetal calf serum and chased in cold
Dulbecco’s modified Eagle’s medium, 10% fetal calf serum for up to 24 h.
Where indicated, culture medium was supplemented with 10 M lacta-
cystin, 50 M MG132, or 0.4 mM chloroquine. Cells were harvested in
lysis buffer, and lysates immunoprecipitated with the anti-FLAG anti-
body and protein G-Sepharose were subjected to SDS-PAGE, trans-
ferred to nitrocellulose membrane, and exposed to x-ray film. Band
intensities were quantitated using Image QuaNT version 4.2a (Molec-
ular Dynamics). N4WBP5 half-lives were calculated using SigmaPlot
4.0 software assuming first order decay.
Immunofluorescence—N18 cells grown on coverslips were fixed for 15
min in 2% paraformaldehyde and permeabilized in 0.2% Triton X-100
for 2 min. Where indicated, cells were treated with 5 g/ml of brefeldin
A (BFA) at 37 °C for 45 min prior to fixing. The fixed cells were stained
with affinity-purified anti-N4WBP5 polyclonal antibody (7.25 g/ml)
and anti-GM130 monoclonal (BD Transduction Laboratory) at 6.25
g/ml for 30 min at room temperature followed by rhodamine-conju-
gated anti-rabbit antibody at 10 g/ml (Chemicon) and fluorescein
isothiocyanate-conjugated anti-mouse antibody at 10 g/ml (Chemicon)
for 30 min at room temperature. All antibodies were diluted in phos-
phate-buffered saline, 2% fetal bovine serum.
Transient Transfection Experiments—Baby hamster kidney cells
were transfected with pcDNA3-NWBP5-FLAG. After an overnight in-
cubation, cells were treated with cycloheximide for 4 h to prevent new
protein synthesis. Cells were fixed and double labeled with antibodies
to the FLAG (data not shown) or the affinity-purified N4WBP5 antibody
together with antibodies to GM130 as above.
RESULTS
Characterization of N4WBP5—Full-length cDNA for
N4WBP5 was identified in a far-Western screen of a day 16
embryonic mouse cDNA library (29). N4WBP5 is a 221 amino
acid protein with a predicted size of 26 kDa containing two
PPXY (PY) motifs within the amino-terminal region (Fig. 1A).
N4WBP5 contains three hydrophobic regions in the carboxyl-
terminal region that correspond to three predicted transmem-
brane domains using the TMPRED software. A TBLASTN
search of GenBankTM revealed a human counterpart of mouse
N4WBP5 (GenBankTM hypothetical protein MGC10924 similar
to Nedd4 WW-binding protein 5) and highly related homolo-2 Primer sequences are available upon request.
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FIG. 1. The N4WBP5 forms part of an evolutionarily conserved family of transmembrane proteins. A, hydrophobicity of the N4WBP5
protein was estimated using the Kyte-Doolittle program, and transmembrane domains (TM) were predicted using the TMPRED program. B,
multiple sequence alignments of N4WBP5 and its homologues. Identical residues are boxed in black, similar residues are boxed in gray, PY motifs
are underlined by thick bars, whereas transmembrane domains are underlined with thin bars. The sequences for N4WBP5 and their homologues
were derived by sequencing of expressed sequence tag clones or were obtained from the GenBankTM data base. C, a phylogeny tree showing
N4WBP5 and N4WBP5A as distinct proteins that probably evolved from a common ancestral protein in Drosophila.
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gous proteins in mammals that we have termed N4WBP5A
(GenBankTM accession number AAL05872). N4WBP5A shares
52% identity and 79% similarity to N4WBP5 (Fig. 1B).
N4WBP5A proteins also contain the two conserved PY motifs,
which correspond to the PY motifs in N4WBP5. A homologue of
N4WBP5 and N4WBP5A in Drosophila melanogaster (CG8056,
FIG. 2. mRNA expression analysis
of N4WBP5 in mouse and human. A, a
mouse multiple tissue Northern blot
(CLONTECH) containing 2 g of each
poly(A) RNA was hybridized to a mouse
N4WBP5 cDNA probe (upper panel). The
N4WBP5 gene was expressed as two tran-
scripts, 2.1 and 1.2 kb in size. In the
lower panel in A, the same blot was hy-
bridized to a human -actin control probe
(CLONTECH). B, a full-length human
N4WBP5 cDNA probe was hybridized to a
human multiple tissue expression array
(CLONTECH). C, a key indicating vari-
ous RNA samples loaded on the human
multiple tissue expression array.
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GenBankTM accession number AAF49316) indicates that these
proteins form an evolutionarily conserved family (Fig. 1C). An
amino acid sequence alignment of mouse, human, and Dro-
sophila N4WBP5 and mouse and human N4WBP5A is shown
(Fig. 1B). A single PY motif exists in Drosophila N4WBP5. The
three predicted transmembrane domains are conserved be-
tween each of the proteins. The construction of a phylogenetic
tree indicated that the Drosophila protein is more closely re-
lated to N4WBP5 than N4WBP5A and suggests that mamma-
lian N4WBP5 and N4WBP5A are likely to have evolved from
the Drosophila N4WBP5 gene. An analysis of the human ge-
nome sequence in public data bases suggests that N4WBP5
and N4WBP5A are not linked and are located on chromosomes
5q24 and 13q23, respectively.
N4WBP5 Transcript Is Widely Expressed—Northern blot
analysis of RNA derived from mouse tissues suggested that
N4WBP5 has two transcripts of 2.1 and 1.2 kb (Fig. 2A). Ex-
pression is highest in the adult liver, brain, kidney, and heart
with the larger transcript predominating in these tissues.
Lower level expression is apparent in the adult lung and testis,
and in the testis a similar amount of both transcripts is pres-
ent. A human multiple tissue expression array (CLONTECH)
was probed with a full-length human N4WBP5 cDNA probe to
determine the sites of expression in the human. The N4WBP5
transcript is detected in most adult tissues (Fig. 2, B and C).
High levels of expression are seen in adult brain tissues includ-
ing the left and right cerebellum, pituitary and thalamus. High
expression is also seen in the kidney, liver, testis, salivary
gland, and placenta of the adult and in the brain, kidney, and
lung of the fetus. However, very low or no expression can be
detected in a range of human cell lines (Fig. 2, B and C, column
10).
The PY Motifs of N4WBP5 Interact with the WW Domains of
Nedd4—We have previously shown that either individually or
together the WW domains of mouse Nedd4 can interact with
the PY motifs of N4WBP5 (29). The mutation of PY motif 1 of
N4WBP5 greatly reduces the interaction between the 32P-la-
beled GST fusion protein containing all three WW domains of
Nedd4 and N4WBP5, whereas the mutation of PY motif 2 had
little effect. Individually, each WW domain of Nedd4 was also
able to interact with the PY motifs of N4WBP5. The mutation
of either PY motif of N4WBP5 had little effect on the interac-
tion with WW domain 1, suggesting that this weak interaction
is not mediated via the PY motifs. However, the mutation of PY
motif 1 greatly reduced the interaction between WW domains 2
and 3 of Nedd4 and N4WBP5 (29). To further characterize the
interaction between Nedd4 and N4WBP5, we carried out far-
Western analysis in which the WW domains of mouse Nedd4
expressed as GST fusion proteins were run on SDS-PAGE gels
(Fig. 3A) and probed with 32P-labeled GST fusions containing
both PY motifs of N4WBP5. The PY motifs of N4WBP5 inter-
acted with wild type WW domains 1–3 of mNedd4 or mutants
in which one WW domain was mutated (Fig. 3B). The mutation
of PY motif 1 of N4WBP5 greatly reduced these interactions,
whereas the mutation of PY motif 2 has little effect, indicating
that PY1 has a much higher affinity for the WW domains of
Nedd4 than PY2 (Fig. 3, C and D). When individual WW
domains of mouse Nedd4 were expressed as GST fusions, wild
type N4WBP5 interacted strongly with WW domains 2 and 3
but not with WW1 (Fig. 3B). Again, the mutation of PY1 of
N4WBP5 almost completely abolished this interaction,
whereas the mutation of PY2 somewhat reduced this interac-
tion (Fig. 3, C and D). Although PY1 is clearly the main con-
tributor to WW domain binding, because the PY1 mutant
showed small but significant binding to Nedd4 WW2, both PY
FIG. 3. The PY motifs of N4WBP5 interact with the WW do-
mains of Nedd4 with varying affinity. A, Coomassie Blue-stained
gel of GST WW domain fusion proteins. The first lane contains GST
alone, and molecular mass markers in kDa are indicated on the right-
hand side of the gel. The lanes marked mWW1–3 contain GST fusion
proteins containing all three WW domains of mouse Nedd4. In the lane
marked wt, all WW domains were in wild type configuration. In the
following three lanes one of the WW domains (shown as 1*, 2*, and 3*)
was mutated leaving two intact WW domains. The last six lanes contain
GST fusion proteins of individual WW domains in wild type (1, 2, and 3)
or mutant (1*, 2*, and 3*) configuration. B–D, far-Western blots of the
gel in A or identical gels probed with a 32P-labeled N4WBP5-GST
protein comprising the amino-terminal 113 amino acids of N4WBP5
fused to the carboxyl-terminal of GST. This region of N4WBP5 contains
both PY motifs. In B, the blot was probed with the fusion protein
containing both PY motifs. In C, the blot was probed with the fusion
protein in which the first PY motif, PPPY (Fig. 1A, PY1), was mutated
to PPPA leaving the second PY motif (PY2) intact. In D, the blot was
probed with the fusion protein in which the PY2 motif, PPSY, was
mutated to PPSA leaving PY1 motif intact. A N4WBP5-GST probe with
both PY motifs mutated did not bind to any of the WW domains of
Nedd4 (data not shown).
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motifs of N4WBP5 may contribute to Nedd4 binding, albeit
with significantly different affinities.
Nedd4 Interacts with N4WBP5 in Transfected Cells—To in-
vestigate the possible interaction between N4WBP5 and Nedd4
in vivo, coimmunoprecipitation experiments were performed in
transfected COS cells. Cells were cotransfected with pCXN2-
Nedd4, and either pcDNA3 or pcDNA3-N4WBP5-FLAG
(N4WBP5) or pcDNA3-N4WBP5-FLAG with both PY motifs
mutated and immunoprecipitated with preimmune serum or
rabbit polyclonal antiserum to Nedd4 (N4). In cells cotrans-
fected with Nedd4 and N4WBP5, the proteins were coimmuno-
precipitated with anti-Nedd4 antiserum, indicating that the
proteins interact in vivo (Fig. 4A). Only a very weak interaction
was seen when N4WBP5 lacking functional PY motifs was
coexpressed with Nedd4, indicating that the association be-
tween these proteins in vivo is predominantly mediated via
PY-WW interactions. Control immunoblotting experiments
showed that both N4WBP5 and N4WBP5 PYm proteins were
efficiently expressed in transfected cells (Fig. 4B), and that
both sets of transfected cells have roughly equivalent amounts
of Nedd4 protein (Fig. 4C).
WW Domains from Several Nedd4 Family Members Interact
with N4WBP5—To test whether N4WBP5 can interact with
other proteins of the Nedd4 family, we analyzed the binding of
the GST-WW domains from various Nedd4-like proteins with
N4WBP5 by far-Western analysis (Fig. 5). Previous studies
have shown that the binding between WW domains of Nedd4
family members and their ligands is very specific. For example,
ENaC subunits only interact with the WW domains of Nedd4
and Nedd4–2, both of which are known to regulate ENaC, and
not to the WW domains of KIAA0322, Smurf1, WWP2/AIP2,
AIP4, and Itch (27). Equivalent amounts of GST-WW domain
fusion proteins, as determined by SDS-PAGE and Coomassie
Blue staining, were electrophoresed by SDS-PAGE (Fig. 5A)
and transferred to nitrocellulose membrane. Filters were
probed with a 32P-labeled GST-N4WBP5 fusion protein and
exposed to x-ray film. Interestingly, N4WBP5 bound to the WW
domains of human Nedd4, Nedd4–2, KIAA0322, WWP2/AIP2,
AIP4, and mouse Itch with varying affinities but failed to
interact with the WW domains of Smurf1 (Fig. 5B). In control
experiments, under identical conditions, only Nedd4 and
Nedd4–2 WW domains interacted with ENaC subunits (data
not shown). These results suggest that in vivo N4WBP5 may
FIG. 5. The PY motifs in N4WBP5 interact with the WW do-
mains of multiple Nedd4 family members. Escherichia coli extracts
expressing various GST-WW proteins were blotted and probed with a
32P-labeled N4WBP5-GST protein comprising the amino-terminal 113
amino acids of N4WBP5 fused to the carboxyl-terminal of GST. A,
Coomassie Blue-stained gel of GST-WW domain fusion proteins. B,
far-Western blot of the GST-WW domain proteins probed with 32P-
labeled GST-N4WBP5.
FIG. 4. Nedd4 interacts with
N4WBP5 in transfected cells. COS
cells were cotransfected with pCXN2-
Nedd4 and either pcDNA3 vector (V),
pcDNA3-N4WBP5-FLAG (N4WBP5) or
pcDNA3-N4WBP5-FLAG with both PY
motifs mutated (N4WBP5 PY m) and har-
vested in lysis buffer 36 h posttransfec-
tion. A, lysates were immunoprecipitated
with either preimmune serum (PI) or
Nedd4ab1 rabbit polyclonal antiserum
(N4), subjected to SDS-PAGE, and immu-
noblotted with an anti-FLAG antibody.
Lysates were also subjected to SDS-
PAGE prior to immunoprecipitation to ex-
amine the presence of N4WBP5 using the
anti-FLAG antibody (B) and Nedd4 using
Nedd4ab1 (C).
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interact with a number of Nedd4 family members, not only
Nedd4 itself.
N4WBP5 Is Ubiquitinated—A portion of overexpressed
N4WBP5 migrates as high molecular mass complex when sub-
jected to SDS-PAGE. COS cells were transfected with
N4WBP5-FLAG, and lysates were subjected to SDS-PAGE and
immunoblotted with anti-FLAG antibody. A short immunoblot
exposure time shows a single band corresponding to the
N4WBP5-FLAG protein migrating at its expected size of 26
kDa (Fig. 6A, short). Longer exposure times reveal a portion of
N4WBP5 migrating as a high molecular mass complex (Fig. 6A,
medium and long). To determine whether the high molecular
mass complex reflects a pool of ubiquitinated N4WBP5, COS
cells were cotransfected with ubiquitin-HA and pcDNA3 or
N4WBP5-FLAG, and lysates were immunoprecipitated with a
control antibody or anti-FLAG antibody. The blot was probed
with anti-FLAG to show immunoprecipitation of N4WBP5 (Fig.
6C) and anti-HA to identify ubiquitinated proteins (Fig. 6B).
FIG. 6. N4WBP5 is ubiquitinated. A, a fraction of N4WBP5 protein migrates as part of a high molecular mass complex in SDS-PAGE gels. COS
cells were transiently transfected with pcDNA3-N4WBP5-FLAG, harvested 36 h posttransfection, subjected to SDS-PAGE, and immunoblotted
with an anti-FLAG antibody. Short, medium, and long exposures of blots are shown. N4WBP5 is only detected in the lanes with transfected cell
lysates () as a 26-kDa protein. In longer exposures, a fraction of N4WBP5 appears to migrate in a high molecular mass complex. C, COS cells
were cotransfected with either the vector pcDNA3 () or pcDNA3-N4WBP5-FLAG () and a HA-tagged ubiquitin expression plasmid () and
harvested 36 h posttransfection. B, lysates were immunoprecipitated with either an isotype matched mouse monoclonal antibody (lanes marked
C) or an anti-FLAG antibody (lanes marked F), subjected to SDS-PAGE, and immunoblotted with an anti-HA antibody to detect the presence of
ubiquitinated N4WBP5 species. The bands corresponding to monoubiquitinated (monoub), diubiquitinated (diub), and polyubiquitinated (polyub)
N4WBP5 species are indicated. In C, lysates were subjected to SDS-PAGE prior to immunoprecipitation to examine the presence of N4WBP5 using
the anti-FLAG antibody.
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Where cells were cotransfected with N4WBP5 and ubiquitin-HA,
ubiquitinated forms of N4WBP5 could be detected. These higher
molecular mass forms of N4WBP5 reflect monoubiquitinated (34
kDa), diubiquitinated (42 kDa), and polyubiquitinated (high mo-
lecular mass complexes) forms of N4WBP5 (Fig. 6B).
Nedd4 May Regulate the Stability of N4WBP5—Pulse-
chase experiments were carried out to assess the stability of
N4WBP5-FLAG in cells cotransfected with Nedd4 or a cata-
lytically inactive cysteine mutant of Nedd4. COS cells were
cotransfected with N4WBP5-FLAG and pCXN2-Nedd4 or the
catalytically inactive cysteine mutant of Nedd4 pCXN2-
Nedd4 cm. Following metabolic labeling, cultures were
chased for up to 24 h in the absence of the label. N4WBP5 was
immunoprecipitated with the anti-FLAG antibody. Initial
pulse-chase experiments revealed that the half-life of
N4WBP5 was 10 h in COS cells. When cotransfected with
the vector control, 25% N4WBP5 remained by 24 h. In
comparison, when cotransfected with pCXN2-Nedd4, only 5%
N4WBP5 remained by this time point. Cotransfection with
the catalytic cysteine mutant of Nedd4 led to 20% of labeled
N4WBP5 remaining by 24 h (Fig. 7, A and B). Consistent with
the results in Fig. 7, A and B, the calculated half-lives of
N4WBP5 under various conditions were 10.3  1.4 h for
N4WBP5  vector, 5.4  0.4 h for N4WBP5  Nedd4, and
8.2  0.9 h for N4WBP5  Nedd4 cm. Thus, cotransfection
with the active form of Nedd4 significantly increased the
turnover rate of N4WBP5, suggesting that N4WBP5 is a
target for the ubiquitin-ligase activity of Nedd4. These re-
sults were also supported by immunoblot analysis of cells
cotransfected with N4WBP5 and Nedd4, Nedd4 cm, or the
WW domains of Nedd4. Reduced levels of N4WBP5 protein
were seen when coexpressed with catalytically active but not
inactive Nedd4 (data not shown).
We also carried out pulse-chase experiments in the presence
of the proteasome inhibitors lactacystin and MG132 or the
lysosomal inhibitor chloroquine to determine whether
N4WBP5 is degraded via the proteasomal or lysosomal path-
way. Treatment with proteasomal inhibitors had a moderate
FIG. 7. Stability of N4WBP5 protein
may be regulated by Nedd4. COS cells
were transfected with 1 g of N4WBP5-
FLAG and 3 g of pCXN2, pCXN2-Nedd4
(Nedd4), or pCXN2-Nedd4 cysteine mu-
tant (Nedd4 cm). Cells were metabolically
labeled and chased for up to 24 h, and
N4WBP5-FLAG immunoprecipitated
with an anti-FLAG antibody. A, Example
of a pulse-chase experiment showing the
stability of N4WBP5 in cells cotransfected
with pCXN2, pCXN2-Nedd4, or pCXN2-
Nedd4 cm. B, data showing quantification
of pulse-chase experiments. Each value is
expressed as a percentage of the amount
of N4WBP5 at 0 h. Data were from three
independent experiments, each done in
triplicate, and error bars represent
mean  S.E. C and D are representative
examples of pulse-chase experiments car-
ried out in the presence of proteasome
inhibitors lactacystin (lact) or MG132 (C)
or the lysosomal inhibitor chloroquine
(chlor) (D). In D, U indicates untrans-
fected cells.
N4WBP5 Is a Novel Golgi Protein9314
 at UQ Library on October 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
but reproducible effect on N4WBP5 stability with higher levels
of N4WBP5 protein remaining after 18 h in the presence of the
inhibitors (Fig. 7C). Similarly, the use of the lysosomal inhib-
itor chloroquine moderately decreased the turnover rate of
N4WBP5 protein (Fig. 7D). These data suggest that both pro-
teasomal and lysosomal/endosomal pathways are involved in
the turnover of N4WBP5.
N4WBP5 Is a Golgi-associated Protein—Polyclonal antisera
to N4WBP5 were generated by inoculation of rabbits with the
amino-terminal domain of N4WBP5 expressed as a GST fusion
protein. An affinity-purified antiserum was used to detect en-
dogenous N4WBP5 protein in a range of cell lines. In immuno-
blot experiments, moderate amounts of N4WBP5 were detected
in the mouse neuroblastoma cell line N18 and human embry-
onic kidney cell line HEK 293T, whereas very low levels of
expression were seen in mouse NIH-3T3 fibroblasts and pri-
mate COS cells (Fig. 8A). The N4WBP5 protein in HEK 293T
and COS cells comigrates with overexpressed N4WBP5,
whereas the N4WBP5-specific band in N18 and NIH-3T3 ap-
pears to migrate with a slightly higher molecular mass (Fig.
8A). The reason for this finding is currently unclear.
The subcellular localization of endogenous N4WBP5 was
assessed in N18 cells by immunohistochemistry and subcellu-
lar fractionation. Endogenous N4WBP5 has a perinuclear lo-
calization with a Golgi-like appearance (Fig. 8B). Costaining
with an antibody to the Golgi matrix protein GM130 (33) indi-
cates that N4WBP5 is indeed localized in Golgi structures (Fig.
8, C and D). Localization in the vesicular fraction was con-
firmed by subcellular fractionation (results not shown). In
some cells, the anti-N4WBP5 antibody also stained nuclear
components. However, cell fractionation results and anti-FLAG
staining of cells overexpressing N4WBP5-FLAG did not indi-
cate that N4WBP5 localized to the nucleus (data not shown).
Therefore, we believe that the nuclear staining is likely to
reflect the cross-reactivity of the antibody. The subcellular
localization of N4WBP5 protein and the predicted transmem-
brane domains within the carboxyl-terminal region of N4WBP5
suggest that N4WBP5 is an integral Golgi membrane protein.
BFA, an inhibitor of the endoplasmic reticulum-Golgi transport
of proteins, has the unique property of effecting a rapid in-
crease of Golgi cisternae volume and a subsequent loss of a
recognizable Golgi apparatus in treated cells (34). Therefore,
we tested whether BFA treatment affects N4WBP5 localiza-
tion. As shown in Fig. 8, E–J, BFA treatment of N18 cells
resulted in an altered localization of both GM130 and
N4WBP5, confirming that N4WBP5 is associated with the
Golgi complex.
Ectopic Expression of N4WBP5 Disrupts Golgi Structure—To
further study the subcellular localization of N4WBP5, we used
FLAG-tagged N4WBP5 expression constructs. Transfection of
pcDNA3-N4WBP5-FLAG into baby hamster kidney cells fol-
lowed by the detection of the protein with anti-FLAG antibody
(data not shown) or affinity-purified N4WBP5 antibody to-
gether with antibodies to GM130 showed that in some cells
FIG. 8. N4WBP5 is an integral Golgi
protein. A, upper panel, immunoblot
analysis of equivalent amounts of protein
from a range of cell lines probed with af-
finity-purified anti-N4WBP5 antibody.
Lower panel, immunoblot as shown above
was probed with monoclonal anti--actin
antibody. B–J, the columns show N18 cell
labeling for N4WBP5 (panels B, E, and H)
or GM130 (panels C, F, and I) with the
merged images (panels D, G, and J) show-
ing both N4WBP5 (red) and GM130
(green). N18 cells were double labeled by
immunofluorescence with antibodies to
N4WBP5 and the Golgi matrix protein
GM130. N4WBP5 was detected with rho-
damine-conjugated anti-rabbit secondary
antibody. GM130 was detected with fluo-
rescein isothiocyanate conjugated-anti-
mouse secondary antibody. B–D show im-
ages of untreated cells, whereas E–J are
images of cells treated with BFA for 45
min prior to fixation and immuno-
staining. Note that BFA treatment alters
the localization of both N4WBP5 and
GM130. Scale bar  5 m.
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N4WBP5 was associated with the Golgi (Fig. 9, J–L, upper
cells). However, the ectopic expression of the protein also re-
sulted in its mislocalization (Fig. 9, D–L). Note that cells were
treated with cycloheximide for 4 h prior to fixation to block
protein synthesis. This treatment generally decreased endo-
plasmic reticulum staining but had no detectable effect on the
general labeling pattern or on Golgi markers (data not shown).
In many cells, N4WBP5 characteristically showed a punctate
labeling with partial overlap with GM130 (Fig. 9, A–C). Inter-
estingly, most of the N4WBP5-transfected cells showed a dis-
ruption of the GM130 staining, which was more punctate or
tubular than in the majority of untransfected cells (Fig. 9, A–L).
This was particularly evident in the higher expressing cells as
shown in Fig. 9, J–L, in which both GM130 and NWBP5 show
a tubular staining pattern in the transfected cells. These re-
sults indicate that the ectopic expression of N4WBP5 causes a
disruption of the Golgi structure and that the altered localiza-
tion of N4WBP5 and GM130 in N4WBP5-transfected cells is
probably to be attributed to the disruption of the Golgi complex.
As overexpression of several Golgi-associated proteins, such as
giantin and GCP60, has been shown to disrupt Golgi structure
(35–37), our results suggest that N4WBP5 is involved in the
structural maintenance of the Golgi complex. Consistent with
our prediction noted above, no significant nuclear localization
of N4WBP5 was apparent in transfected cells.
DISCUSSION
In this study, we have described the identification of a novel
protein, N4WBP5, associated with the Golgi complex that is a
potential target for ubiquitination by the Nedd4 family of pro-
teins. In mammals, a closely related protein, which we have
named N4WBP5A, also exists. Whereas two such proteins are
present in mammals, a single related protein of unknown func-
tion is present in Drosophila that is likely to be a common
ancestor for the mammalian proteins. Although there are no
obvious orthologues of N4WBP5/N4WBP5A in yeast, the con-
servation of these proteins from insects to mammals suggest
that they play important roles in cell function.
N4WBP5 and N4WBP5A are characterized by three poten-
tial transmembrane domains, but they do not share any signif-
icant similarity or specific domains with the known proteins in
the sequence data base. The presence of transmembrane do-
mains suggest that N4WBP5 and N4WBP5A are likely to be
integral membrane proteins. The localization of N4WBP5 in
the Golgi complex is consistent with this prediction. N4WBP5
and N4WBP5A contain two PY motifs, both of which are con-
served in human and mouse proteins. Both these PY motifs are
located toward the amino termini of the proteins. We predict a
membrane topology of these proteins in which the amino ter-
mini of the proteins face the cytosolic side enabling them to
interact with cytosolic Nedd4-like proteins and the carboxyl
termini would face the luminal side. In vitro experiments sug-
gest that both PY motifs are able to interact with WW domains
2 and 3 of mouse Nedd4 but not with the WW domain 1.
However, the strongest interaction is between PY motif 1 and
WW2, and thus it is likely that in vivo, N4WBP5 binds Nedd4
predominantly via PY motif 1.
We have shown that N4WBP5 can undergo ubiquitination,
and that Nedd4 can to a small but significant extent regulate
the turnover of the protein, suggesting that N4WBP5 ubiquiti-
nation is likely to be mediated by Nedd4 or a Nedd4 family
member. N4WBP5 is a relatively long lived protein with a
half-life of 10 h. The stability of N4WBP5 was significantly
increased by the overexpression of the Nedd4 WW domains or
treatment of cells with proteasome inhibitors lactacystin and
MG132 or a lysosomal inhibitor chloroquine, further suggest-
ing the involvement of ubiquitination in the regulation of
N4WBP5 protein turnover.
The specificity of interactions between various WW domains
and their ligands is governed by both the motifs themselves
and the surrounding amino acids (38). The interactions be-
tween WW domains and ligands are therefore quite specific.
For instance, the PY motifs in the carboxyl termini of ENaC
subunits only interact with the specific WW domains of Nedd4
and Nedd4–2, two highly related proteins, but not with the
WW domains of other Nedd4 family members (27). Therefore, it
is interesting that N4WBP5 can interact with the WW domains
derived from several of the Nedd4 family members. This find-
ing suggests that N4WBP5 may interact with multiple mem-
bers of the Nedd4 family in vivo. It is tempting to speculate
that N4WBP5 may act as an adaptor to recruit one or more
Nedd4 family of ubiquitin-protein ligases to the Golgi complex.
In previous studies (39–42), Nedd4 has been shown to interact
with proteins in various subcellular compartments including
the plasma membrane, mitochondria, nucleus, cytosol, and
FIG. 9. Ectopic expression of N4WBP5 disrupts Golgi struc-
ture. Baby hamster kidney cells transfected with N4WBP5 were
treated with cycloheximide to prevent new protein synthesis and double
labeled with affinity-purified N4WBP5 antibody together with antibod-
ies to GM130. The columns show labeling for NWBP5 (panels A, D, G,
and J) or GM130 (panels B, E, H, and K) with the merged images
(panels C, F, I, and L) showing both N4WBP5 (green) and GM130 (red).
NWBP5 characteristically shows a punctate labeling with a partial
overlap with GM130 (small arrows in panels A and B). Note that most
of the transfected cells show a disruption of the GM130 staining that is
more punctate or tubular than in the majority of untransfected cells
(large arrows in panels B, E, and K). This is particularly evident in the
higher expressing cells as shown in panels G–L in which both GM130
and N4WBP5 show a tubular staining pattern (small arrows) in the
transfected cells. Scale bar  5 m.
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lipid rafts. In most cells, the majority of Nedd4 protein is
cytosolic, but it can be recruited to various cellular compart-
ments depending upon signaling (6, 39–42). This is consistent
with the concept that Nedd4 can target multiple proteins for
ubiquitination, thus controlling many cellular processes such
as regulation of cell surface channels and transporters, protein
trafficking, regulation of cell survival and apoptosis, receptor
signaling, virus budding, and transcription (12, 14, 21, 43, 44).
Our demonstration that Nedd4 and Nedd4-like proteins can
also target a Golgi-associated protein further emphasizes the
pleiotropic nature of cellular regulation by the Nedd4 family
members.
The Golgi complex plays a key role in modification, sorting,
and trafficking of proteins exported from the endoplasmic re-
ticulum (45). Nedd4 and its yeast homologue Rsp5 have been
implicated in the regulation of sorting at the trans-Golgi net-
work, trafficking to endosomes, endocytosis, and virus budding
(reviewed in Ref. 14). A recently described function of Rsp5 is
ubiquitination-dependent trafficking of tryptophan permease
Tat2 and general amino acid permease Gap1 (14, 17, 18, 46).
Under poor nitrogen nutrient conditions, Tat2 is transported
from the Golgi to vacuoles by a pathway that is dependent on
Rsp5 and ubiquitin. In contrast to Tat2, Gap1 permease is
targeted to the vacuole when nitrogen sources are rich. How-
ever, in both cases, Rsp5-dependent ubiquitination determines
whether the permeases are transported to the cell membrane
or degraded in the vacuole. Gap1 intracellular trafficking is
controlled by polyubiquitination mediated by Rsp5 and re-
quires Bul1 and Bul2 proteins, which are believed to act as
adaptors to bring together Rsp5 and Gap1 (17). Although no
analogous pathways have been identified in mammals, it is
possible that N4WBP5 and its relative N4WBP5A are a part of
the protein sorting/trafficking apparatus at the Golgi that act
as adaptors for various Nedd4-like proteins and their potential
targets. Our recent data suggest that N4WBP5A is associated
with Golgi and post-Golgi vesicles.3 We are now testing
whether N4WBP5 and N4WBP5A are indeed involved in the
regulation of ubiquitin-dependent trafficking of the targets of
Nedd4-like proteins.
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